Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | DD72H | — |
received a dose of Bexsero after a temperature excursion of 68 °F to 72 °F for 15 hours.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 24-year-old female patient who received Men B NVS (Bexsero) (batch number DD72H, expiry date 30-NOV-2027) for prophylaxis. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incorrect storage of drug (Verbatim: received a dose of Bexsero after a temperature excursion of 68 °F to 72 °F for 15 hours.). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-MAR-2025 The pharmacist reported that they administered Bexsero to a patient after a temperature excursion and Bexsero vaccine was exposed to 68 degree Fahrenit to 72 degree Fahrenit for 15 hours, which led to incorrect storage of drug. The reporter asked do they have extended stability data for this vaccine.